Delmar, NY, United States of America

Jeffrey Schneiderheinze

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Schneiderheinze. Retrieved from https://idiyas.com/inventor/jeffrey-schneiderheinze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey Schneiderheinze

Introduction

Jeffrey Schneiderheinze is an accomplished inventor based in Delmar, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of microchip capillary electrophoresis assays and reagents. With a total of 3 patents to his name, Schneiderheinze continues to push the boundaries of innovation in protein drug analysis.

Latest Patents

Schneiderheinze's latest patents focus on microchip capillary electrophoresis (MCE) assays and reagents. These innovations are designed to assess the purity of protein drug product samples and identify impurities effectively. The methods he has developed for analyzing analytes in protein drug samples are crucial for ensuring the quality and safety of biopharmaceuticals.

Career Highlights

Currently, Jeffrey Schneiderheinze is employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in biotechnology to advance the company's research and development efforts. His work has been instrumental in enhancing the analytical capabilities of protein drug products.

Collaborations

Throughout his career, Schneiderheinze has collaborated with talented individuals such as Timothy Riehlman and Gabriel Carreau. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Jeffrey Schneiderheinze's contributions to the field of biotechnology through his patents and work at Regeneron Pharmaceuticals, Inc. highlight his commitment to advancing drug analysis techniques. His innovative spirit continues to inspire those in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…